ITTO960275A0 - - Google Patents

Info

Publication number
ITTO960275A0
ITTO960275A0 ITTO960275A ITTO960275A ITTO960275A0 IT TO960275 A0 ITTO960275 A0 IT TO960275A0 IT TO960275 A ITTO960275 A IT TO960275A IT TO960275 A ITTO960275 A IT TO960275A IT TO960275 A0 ITTO960275 A0 IT TO960275A0
Authority
IT
Italy
Application number
ITTO960275A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITTO960275A0 publication Critical patent/ITTO960275A0/it
Priority to IT96TO000275A priority Critical patent/IT1286302B1/it
Priority to PT96928398T priority patent/PT892790E/pt
Priority to AT96928398T priority patent/ATE264312T1/de
Priority to ES96928398T priority patent/ES2216057T3/es
Priority to AU67885/96A priority patent/AU6788596A/en
Priority to DE69632206T priority patent/DE69632206T2/de
Priority to EP96928398A priority patent/EP0892790B1/en
Priority to CA002251308A priority patent/CA2251308A1/en
Priority to JP53577097A priority patent/JP3987113B2/ja
Priority to US09/155,993 priority patent/US5985885A/en
Priority to PCT/EP1996/003370 priority patent/WO1997037979A1/en
Publication of ITTO960275A1 publication Critical patent/ITTO960275A1/it
Application granted granted Critical
Publication of IT1286302B1 publication Critical patent/IT1286302B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT96TO000275A 1996-04-10 1996-04-10 Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso IT1286302B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT96TO000275A IT1286302B1 (it) 1996-04-10 1996-04-10 Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso
EP96928398A EP0892790B1 (en) 1996-04-10 1996-07-31 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
AT96928398T ATE264312T1 (de) 1996-04-10 1996-07-31 (2-piperidin-1-yl-4-substituierte)-4-amino-2- chinazolin-derivate mit antihypertensiver wirkung,verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch
ES96928398T ES2216057T3 (es) 1996-04-10 1996-07-31 Nuevos derivados quinazolin-4-a,omp-2-(piperidin-1-ilo-4-sustituidos) que tienen actividad antihipertensora, un metodo para su preparacion y su uso farmaceutico.
AU67885/96A AU6788596A (en) 1996-04-10 1996-07-31 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
DE69632206T DE69632206T2 (de) 1996-04-10 1996-07-31 (2-piperidin-1-yl-4-substituierte)-4-amino-2-chinazolin-derivate mit antihypertensiver wirkung, verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch
PT96928398T PT892790E (pt) 1996-04-10 1996-07-31 Um metodo para a preparacao e uso farmaceutico de novos derivados de quinazolinas-4-amino-2-(piperidina-1-ilo-4-substituidas)
CA002251308A CA2251308A1 (en) 1996-04-10 1996-07-31 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
JP53577097A JP3987113B2 (ja) 1996-04-10 1996-07-31 抗高血圧活性を有する新規キナゾリン―４―アミノ―２―（ピペリジン―１―イル―４―置換）誘導体並びにその製造法および医薬用途
US09/155,993 US5985885A (en) 1996-04-10 1996-07-31 Quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having antihypertensive activity, a method for their preparation and their pharmaceutical use
PCT/EP1996/003370 WO1997037979A1 (en) 1996-04-10 1996-07-31 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96TO000275A IT1286302B1 (it) 1996-04-10 1996-04-10 Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso

Publications (3)

Publication Number Publication Date
ITTO960275A0 true ITTO960275A0 (it) 1996-04-10
ITTO960275A1 ITTO960275A1 (it) 1997-10-10
IT1286302B1 IT1286302B1 (it) 1998-07-08

Family

ID=11414541

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96TO000275A IT1286302B1 (it) 1996-04-10 1996-04-10 Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso

Country Status (11)

Country Link
US (1) US5985885A (it)
EP (1) EP0892790B1 (it)
JP (1) JP3987113B2 (it)
AT (1) ATE264312T1 (it)
AU (1) AU6788596A (it)
CA (1) CA2251308A1 (it)
DE (1) DE69632206T2 (it)
ES (1) ES2216057T3 (it)
IT (1) IT1286302B1 (it)
PT (1) PT892790E (it)
WO (1) WO1997037979A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015019365A1 (en) 2013-08-07 2015-02-12 Cadila Healthcare Limited N-cyanomethylamides as inhibitors of janus kinase
US9682955B2 (en) * 2014-09-09 2017-06-20 Janssen Pharmaceutica Nv Quinazoline derivatives useful as CB-1 inverse agonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
GB1383409A (en) * 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
DE3336409A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
IT1270993B (it) * 1994-03-18 1997-05-26 Recordati Chem Pharm Derivati chinzolilamminici attivi come alfa-antagonisti

Also Published As

Publication number Publication date
ATE264312T1 (de) 2004-04-15
IT1286302B1 (it) 1998-07-08
AU6788596A (en) 1997-10-29
US5985885A (en) 1999-11-16
ITTO960275A1 (it) 1997-10-10
DE69632206D1 (de) 2004-05-19
ES2216057T3 (es) 2004-10-16
EP0892790B1 (en) 2004-04-14
EP0892790A1 (en) 1999-01-27
DE69632206T2 (de) 2005-04-28
WO1997037979A1 (en) 1997-10-16
JP2000508297A (ja) 2000-07-04
JP3987113B2 (ja) 2007-10-03
CA2251308A1 (en) 1997-10-16
PT892790E (pt) 2004-06-30

Similar Documents

Publication Publication Date Title
AR026662A2 (it)
BRPI9713914B8 (it)
IN191849B (it)
IN191059B (it)
IN191220B (it)
IN192216B (it)
ITTO960275A0 (it)
IN186696B (it)
GB9614197D0 (it)
IN180250B (it)
IN188938B (it)
IN187440B (it)
ITGE960067A0 (it)
IN186278B (it)
IN186209B (it)
ITMI960604A0 (it)
IN189086B (it)
ITMI960603A0 (it)
IN184327B (it)
IN182776B (it)
IN182580B (it)
IN181799B (it)
CN3044169S (it)
CN3043416S (it)
EP0932670A4 (it)

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990331